Aion Therapeutic Inc. (AION.CN)

CAD 0.01

(0.0%)

Annual Income Statements

(In CAD)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue 367.47 Thousand - - - - -
Cost of Revenue 652.81 Thousand 17.3 Thousand 65.29 Thousand 1.50 111.05 Thousand -
Gross Profit -285.33 Thousand -17.3 Thousand -65.29 Thousand -1.50 -111.05 Thousand -
Operating Expenses 163.11 Thousand 975.69 Thousand 2.81 Million 2.78 Million 982.64 Thousand 1.7 Million
Selling, General and Administrative Expenses 1.02 Million 587.83 Thousand 1.8 Million 2.65 Million 853.18 Thousand 1.68 Million
Research and Development Expenses - - 953 Thousand - 18.4 Thousand 15.99 Thousand
Other Expenses - - 65.29 Thousand 128.13 Thousand - -34.04 Thousand
Cost and Expenses 1.55 Million 975.69 Thousand 2.81 Million 2.78 Million 982.64 Thousand 1.7 Million
Operating Income -1.19 Million -1.08 Million -2390.86 -2602.23 -996.64 Thousand -1.7 Million
Interest Expense 171.39 Thousand 149.84 Thousand 75.71 Thousand 186.06 Thousand 321.18 Thousand 679.12 Thousand
Income Tax Expense - 41.03 Thousand 75.71 Thousand 186.06 Thousand 321.18 Thousand 679.12 Thousand
Earnings before Tax -6.28 Million -256.65 Thousand -3.81 Million -8.26 Million -672.83 Thousand -4.93 Million
Net Income -6.28 Million -256.65 Thousand -3.81 Million -8.26 Million -672.83 Thousand -5.61 Million
Earnings Per Share Basic -0.02 -0.00 -0.03 -0.09 -0.02 -0.20
Earnings Per Share Diluted -0.02 -0.00 -0.03 -0.09 -0.02 -0.20
Weighted Average Shares Outstanding 265.07 Million 146.39 Million 139.89 Million 93.89 Million 35.88 Million 27.47 Million
Weighted Average Shares Outstanding (Diluted) 265.07 Million 146.39 Million 139.89 Million 93.89 Million 35.88 Million 27.47 Million
Gross Margin -0.78 - - - - -
EBIT Margin -16.53 - - - - -
Profit Margin -17.11 - - - - -
EBITDA -6.07 Million -89.51 Thousand -3.67 Million -7.95 Million -240.59 Thousand -3.44 Million
Earnings Before Tax Margin -3.24 - - - - -

Income Statement Charts